CSF1R copy number changes, point mutations, and RNA and protein overexpression in renal cell carcinomas.
about
Elevated PDGFRB gene copy number gain is prognostic for improved survival outcomes in resected malignant pleural mesotheliomaDifferential effects of CSF-1R D802V and KIT D816V homologous mutations on receptor tertiary structure and allosteric communicationAutocrine CSF-1 and CSF-1 receptor coexpression promotes renal cell carcinoma growth.Mutations in the colony stimulating factor 1 receptor (CSF1R) gene cause hereditary diffuse leukoencephalopathy with spheroids.An integrative study on the impact of highly differentially methylated genes on expression and cancer etiologyStratification of clear cell renal cell carcinoma (ccRCC) genomes by gene-directed copy number alteration (CNA) analysisCSF1R mosaicism in a family with hereditary diffuse leukoencephalopathy with spheroids
P2860
Q34060193-9FC17854-47D8-433D-825B-66E7F96C6C87Q35168745-E785BAC4-7196-410F-A89B-114F6CA26BCBQ35653176-5CD5F714-AC5F-437F-887C-84B28A0B1957Q35705431-B43282F5-AB14-4839-BF9C-6074523497B7Q36274178-F790EA78-2D4A-4DD5-B0AA-EDBA3E544455Q36367103-BB53785D-20ED-4374-BA29-C95CF0126B1DQ36967706-6B728715-735C-42E7-9A47-C6051FDA4816
P2860
CSF1R copy number changes, point mutations, and RNA and protein overexpression in renal cell carcinomas.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
CSF1R copy number changes, poi ...... sion in renal cell carcinomas.
@en
CSF1R copy number changes, poi ...... sion in renal cell carcinomas.
@nl
type
label
CSF1R copy number changes, poi ...... sion in renal cell carcinomas.
@en
CSF1R copy number changes, poi ...... sion in renal cell carcinomas.
@nl
prefLabel
CSF1R copy number changes, poi ...... sion in renal cell carcinomas.
@en
CSF1R copy number changes, poi ...... sion in renal cell carcinomas.
@nl
P2093
P2860
P50
P1433
P1476
CSF1R copy number changes, poi ...... sion in renal cell carcinomas.
@en
P2093
Ana T Martins
Jorge Oliveira
Maria J Soares
P2860
P2888
P304
P356
10.1038/MODPATHOL.2009.43
P407
P577
2009-04-17T00:00:00Z
P6179
1005095117